199 related articles for article (PubMed ID: 35354317)
1. DP1 (Prostaglandin D
Zou F; Li Y; Zhang S; Zhang J
Hypertension; 2022 Jun; 79(6):1203-1215. PubMed ID: 35354317
[TBL] [Abstract][Full Text] [Related]
2. Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7.
Li Y; Li H; Xing W; Li J; Du R; Cao D; Wang Y; Yang X; Zhong G; Zhao Y; Sun W; Liu C; Gao X; Li Y; Liu Z; Jin X; Zhao D; Tan Y; Wang Y; Liu S; Yuan M; Song J; Chang YZ; Gao F; Ling S; Li Y
FASEB J; 2021 Nov; 35(11):e21947. PubMed ID: 34637552
[TBL] [Abstract][Full Text] [Related]
3. Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling.
He Y; Zuo C; Jia D; Bai P; Kong D; Chen D; Liu G; Li J; Wang Y; Chen G; Yan S; Xiao B; Zhang J; Piao L; Li Y; Deng Y; Li B; Roux PP; Andreasson KI; Breyer RM; Su Y; Wang J; Lyu A; Shen Y; Yu Y
Am J Respir Crit Care Med; 2020 May; 201(10):1263-1276. PubMed ID: 31917615
[No Abstract] [Full Text] [Related]
4. NLRP3 Gene Deletion Attenuates Angiotensin II-Induced Phenotypic Transformation of Vascular Smooth Muscle Cells and Vascular Remodeling.
Ren XS; Tong Y; Ling L; Chen D; Sun HJ; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2017; 44(6):2269-2280. PubMed ID: 29262411
[TBL] [Abstract][Full Text] [Related]
5. RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling.
Dai F; Qi Y; Guan W; Meng G; Liu Z; Zhang T; Yao W
Atherosclerosis; 2019 Sep; 288():124-136. PubMed ID: 31362179
[TBL] [Abstract][Full Text] [Related]
6. VSMC-Specific Deletion of FAM3A Attenuated Ang II-Promoted Hypertension and Cardiovascular Hypertrophy.
Xiang R; Chen J; Li S; Yan H; Meng Y; Cai J; Cui Q; Yang Y; Xu M; Geng B; Yang J
Circ Res; 2020 Jun; 126(12):1746-1759. PubMed ID: 32279581
[TBL] [Abstract][Full Text] [Related]
7. Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission.
Lu ZY; Qi J; Yang B; Cao HL; Wang RY; Wang X; Chi RF; Guo CL; Yang ZM; Liu HM; Li B
Cardiovasc Drugs Ther; 2020 Oct; 34(5):605-618. PubMed ID: 32564303
[TBL] [Abstract][Full Text] [Related]
8. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
[TBL] [Abstract][Full Text] [Related]
9. [Overexpression of human EP4 receptor in vascular smooth muscle cells attenuates angiotensin II-induced hypertension in mice].
Xu H; Wang SL; Bao CZ; Ye L; Guan YF; Zhang XY
Sheng Li Xue Bao; 2021 Aug; 73(4):597-605. PubMed ID: 34405216
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II.
Okuno K; Torimoto K; Cicalese SM; Preston K; Rizzo V; Hashimoto T; Coffman TM; Sparks MA; Eguchi S
Hypertension; 2023 Mar; 80(3):668-677. PubMed ID: 36628961
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast Nox2 (NADPH Oxidase-2) Regulates ANG II (Angiotensin II)-Induced Vascular Remodeling and Hypertension via Paracrine Signaling to Vascular Smooth Muscle Cells.
Harrison CB; Trevelin SC; Richards DA; Santos CXC; Sawyer G; Markovinovic A; Zhang X; Zhang M; Brewer AC; Yin X; Mayr M; Shah AM
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):698-710. PubMed ID: 33054395
[TBL] [Abstract][Full Text] [Related]
12. Smooth muscle-specific TMEM16A expression protects against angiotensin II-induced cerebrovascular remodeling via suppressing extracellular matrix deposition.
Zeng XL; Sun L; Zheng HQ; Wang GL; Du YH; Lv XF; Ma MM; Guan YY
J Mol Cell Cardiol; 2019 Sep; 134():131-143. PubMed ID: 31301303
[TBL] [Abstract][Full Text] [Related]
13. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia inducible factor 1α in vascular smooth muscle cells promotes angiotensin II-induced vascular remodeling via activation of CCL7-mediated macrophage recruitment.
Qi D; Wei M; Jiao S; Song Y; Wang X; Xie G; Taranto J; Liu Y; Duan Y; Yu B; Li H; Shah YM; Xu Q; Du J; Gonzalez FJ; Qu A
Cell Death Dis; 2019 Jul; 10(8):544. PubMed ID: 31320613
[TBL] [Abstract][Full Text] [Related]
15. VSMC-specific EP4 deletion exacerbates angiotensin II-induced aortic dissection by increasing vascular inflammation and blood pressure.
Xu H; Du S; Fang B; Li C; Jia X; Zheng S; Wang S; Li Q; Su W; Wang N; Zheng F; Chen L; Zhang X; Gustafsson JÅ; Guan Y
Proc Natl Acad Sci U S A; 2019 Apr; 116(17):8457-8462. PubMed ID: 30948641
[TBL] [Abstract][Full Text] [Related]
16. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
[TBL] [Abstract][Full Text] [Related]
17. Differential baseline expression and angiotensin II-stimulation of leukemia-associated RhoGEF in vascular smooth muscle cells of spontaneously hypertensive rats.
Chiu WC; Juang JM; Chang SN; Wu CK; Tsai CT; Tseng CD; Tseng YZ; Su MJ; Chiang FT
Int J Nanomedicine; 2012; 7():5929-39. PubMed ID: 23233801
[TBL] [Abstract][Full Text] [Related]
18. Loss of smooth muscle cell disintegrin and metalloproteinase 17 transiently suppresses angiotensin II-induced hypertension and end-organ damage.
Shen M; Morton J; Davidge ST; Kassiri Z
J Mol Cell Cardiol; 2017 Feb; 103():11-21. PubMed ID: 27993561
[TBL] [Abstract][Full Text] [Related]
19. CFTR deficiency aggravates Ang II induced vasoconstriction and hypertension by regulating Ca2+ influx and RhoA/Rock pathway in VSMCs.
Zhao L; Yuan F; Pan N; Yu Y; Yang H; Liu Y; Wang R; Zhang B; Wang G
Front Biosci (Landmark Ed); 2021 Dec; 26(12):1396-1410. PubMed ID: 34994155
[TBL] [Abstract][Full Text] [Related]
20. Identification of a cAMP-response element in the regulator of G-protein signaling-2 (RGS2) promoter as a key cis-regulatory element for RGS2 transcriptional regulation by angiotensin II in cultured vascular smooth muscles.
Xie Z; Liu D; Liu S; Calderon L; Zhao G; Turk J; Guo Z
J Biol Chem; 2011 Dec; 286(52):44646-58. PubMed ID: 22057271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
